• Measure Summary
  • NQMC:010196
  • 2013 Jan

Major depressive disorder (MDD): percentage of patients aged 18 years and older with a diagnosis of MDD who received patient education at least once during the measurement period, regarding the minimum specified criteria.

American Psychiatric Association; Physician Consortium for Performance Improvement®

  • Measure Summary
  • NQMC:003506
  • 2007 Jan

Bipolar disorder: the percentage of patients diagnosed and treated for bipolar disorder who are monitored for change in their level-of-functioning in response to treatment.

STABLE Project National Coordinating Council

  • Measure Summary
  • NQMC:010540
  • 2015 Oct

Adherence to antipsychotic medications for individuals with schizophrenia: percentage of members 19 to 64 years of age during the measurement year with schizophrenia who were dispensed and remained on an antipsychotic medication for at least 80 percent of their treatment period.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:003503
  • 2007 Jan

Bipolar disorder: the percentage of patients diagnosed and treated for bipolar disorder who are provided with education and information about their illness and treatment within 12 weeks of initiating treatment.

STABLE Project National Coordinating Council

  • Measure Summary
  • NQMC:010199
  • 2013 Jan

Major depressive disorder (MDD): percentage of patients aged 18 years and older with a new diagnosis or recurrent episode of MDD with documentation of the patient's response to treatment three times in the first 90 days following diagnosis, and, if patient has not improved, documentation of treatment plan review or alteration.

American Psychiatric Association; Physician Consortium for Performance Improvement®

  • Measure Summary
  • NQMC:001622
  • 2005 Jan

Depression: percent of clinically significant depression patients who have a documented Current Patient Health Questionnaire (PHQ) reassessment between 4 to 8 weeks after their last New Episode PHQ.

HRSA Health Disparities Collaboratives: Depression Collaborative

  • Measure Summary
  • NQMC:003495
  • 2007 Jan

Bipolar disorder: percentage of patients with Bipolar I Disorder with depressive symptoms and behaviors who have evidence of use of a mood stabilizing or antimanic agent during the first 12 weeks of pharmacotherapy treatment.

STABLE Project National Coordinating Council

  • Measure Summary
  • NQMC:010532
  • 2015 Oct
  • NQF-Endorsed Measure

Antidepressant medication management (effective continuation phase treatment): percentage of members 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression and who remained on an antidepressant medication for at least 180 days (6 months).

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:001625
  • 2005 Jan

Depression: percent of clinically significant depression patients who have had a documented follow-up 1 to 3 weeks after their last New Episode Patient Health Questionnaire (PHQ).

HRSA Health Disparities Collaboratives: Depression Collaborative

  • Measure Summary
  • NQMC:003492
  • 2007 Jan

Depression: the percentage of patients diagnosed with unipolar depression who receive an initial assessment that considers the risk of suicide.

STABLE Project National Coordinating Council

  • Measure Summary
  • NQMC:004208
  • 2008 Jul

Substance use disorders: percentage of patients aged 18 years and older with a diagnosis of current opioid addiction who were counseled regarding psychosocial AND pharmacologic treatment options for opioid addiction within the 12 month reporting period.

American Psychiatric Association; National Committee for Quality Assurance; Physician Consortium for Performance Improvement®

  • Measure Summary
  • NQMC:010535
  • 2015 Oct
  • NQF-Endorsed Measure

Follow-up after hospitalization for mental illness: percentage of discharges for members 6 years of age and older who were hospitalized for treatment of selected mental illness diagnoses and who had an outpatient visit, an intensive outpatient encounter, or partial hospitalization with a mental health practitioner within 30 days of discharge.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:001628
  • 2005 Jan

Depression: percent of patients with a diagnosis of major depression or dysthymia who, as of their last visit, are taking an antidepressant.

HRSA Health Disparities Collaboratives: Depression Collaborative

  • Measure Summary
  • NQMC:010475
  • 2015 Sep
  • NQF-Endorsed Measure

Adult major depressive disorder (MDD): percentage of patients aged 18 years and older with a diagnosis of MDD who had a suicide risk assessment completed during the visit in which a new diagnosis or recurrent episode was identified.

Physician Consortium for Performance Improvement®

  • Measure Summary
  • NQMC:003504
  • 2007 Jan

Bipolar disorder: the percentage of patients diagnosed and treated for bipolar disorder who are monitored for change in their symptom complex within 12 weeks of initiating treatment.

STABLE Project National Coordinating Council

  • Measure Summary
  • NQMC:009954
  • 2014 Nov
  • NQF-Endorsed Measure

Follow-up care for children prescribed ADHD medication (continuation and maintenance [C&M] phase): percentage of patients 6 to 12 years of age as of the index prescription start date with an outpatient ADHD medication who remained on the medication for at least 210 days and who, in addition to the visit in the initiation phase, had at least two follow-up visits with a practitioner within 270 days (9 months) after the initiation phase ended.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010538
  • 2015 Oct
  • NQF-Endorsed Measure

Diabetes monitoring for people with diabetes and schizophrenia: percentage of members 18 to 64 years of age with schizophrenia and diabetes who had both an LDL-C test and an HbA1c test during the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:003501
  • 2007 Jan

Bipolar disorder: the percentage of patients diagnosed with bipolar disorder and treated with an atypical antipsychotic agent who receive at least one screening for hyperglycemia within the initial 16 weeks of treatment.

STABLE Project National Coordinating Council

  • Measure Summary
  • NQMC:001631
  • 2005 Jan

Depression: percent of patients with diagnosis of major depression or dysthymia who have been on antidepressants for at least 6 months.

HRSA Health Disparities Collaboratives: Depression Collaborative

  • Measure Summary
  • NQMC:003498
  • 2007 Jan

Bipolar disorder: the percentage of patients with bipolar disorder who were monitored for weight gain during initial 12 week period of treatment.

STABLE Project National Coordinating Council